Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Biochem Soc Trans ; 42(6): 1534-7, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25399566

RESUMO

Cytokinesis is the final act of the cell cycle where the replicated DNA and cellular contents are finally split into two daughter cells. This process is very tightly controlled as DNA segregation errors and cytokinesis failure is commonly associated with aneuploidy and aggressive tumours. Protein kinase Cε (PKCε) is a lipid-activated serine/threonine kinase that is part of the PKC superfamily. PKCε plays a complex role in the regulation of migration, adhesion and cytokinesis and in the present article we discuss the interplay between these processes. Integrin-mediated interaction with the actin cytoskeleton is a known regulator of cell adhesion and migration and there is emerging evidence that this pathway may also be essential for cytokinesis. We discuss evidence that a known actin-binding region in PKCε is involved in PKCε-mediated regulation of cytokinesis, providing a link between integrin-mediated stabilization of the cytokinesis furrow and PKCε recruitment.


Assuntos
Ciclo Celular , Isoenzimas/metabolismo , Proteínas Quinases/metabolismo , Integrinas/metabolismo , Transdução de Sinais
2.
Nat Commun ; 11(1): 1396, 2020 03 13.
Artigo em Inglês | MEDLINE | ID: mdl-32170202

RESUMO

The Aurora B abscission checkpoint delays cytokinesis until resolution of DNA trapped in the cleavage furrow. This process involves PKCε phosphorylation of Aurora B S227. Assessing if this PKCε-Aurora B module provides a more widely exploited genome-protective control for the cell cycle, we show Aurora B phosphorylation at S227 by PKCε also occurs during mitosis. Expression of Aurora B S227A phenocopies inhibition of PKCε in by-passing the delay and resolution at anaphase entry that is associated with non-disjunction and catenation of sister chromatids. Implementation of this anaphase delay is reflected in PKCε activation following cell cycle dependent cleavage by caspase 7; knock-down of caspase 7 phenocopies PKCε loss, in a manner rescued by ectopically expressing/generating a free PKCε catalytic domain. Molecular dynamics indicates that Aurora B S227 phosphorylation induces conformational changes and this manifests in a profound switch in specificity towards S29 TopoIIα phosphorylation, a response necessary for catenation resolution during mitosis.


Assuntos
Anáfase/fisiologia , Aurora Quinase B/metabolismo , Metáfase/fisiologia , Mitose/fisiologia , Anáfase/genética , Aurora Quinase B/química , Aurora Quinase B/genética , Caspase 7/metabolismo , Proteínas de Ciclo Celular/metabolismo , Cromátides/metabolismo , Cromatina , Cromossomos/metabolismo , Células HEK293 , Humanos , Metáfase/genética , Mitose/genética , Simulação de Dinâmica Molecular , Fosforilação , Proteína Quinase C-épsilon/metabolismo , Proteínas Recombinantes , Transdução de Sinais/fisiologia
4.
Nat Commun ; 7: 13853, 2016 12 22.
Artigo em Inglês | MEDLINE | ID: mdl-28004745

RESUMO

The 'NoCut', or Aurora B abscission checkpoint can be activated if DNA is retained in the cleavage furrow after completion of anaphase. Checkpoint failure leads to incomplete abscission and a binucleate outcome. These phenotypes are also observed after loss of PKCɛ in transformed cell models. Here we show that PKCɛ directly modulates the Aurora B-dependent abscission checkpoint by phosphorylating Aurora B at S227. This phosphorylation invokes a switch in Aurora B specificity, with increased phosphorylation of a subset of target substrates, including the CPC subunit Borealin. This switch is essential for abscission checkpoint exit. Preventing the phosphorylation of Borealin leads to abscission failure, as does expression of a non-phosphorylatable Aurora B S227A mutant. Further, depletion of the ESCRT-III component and Aurora B substrate CHMP4C enables abscission, bypassing the PKCɛ-Aurora B exit pathway. Thus, we demonstrate that PKCɛ signals through Aurora B to exit the abscission checkpoint and complete cell division.


Assuntos
Aurora Quinase B/metabolismo , Proteína Quinase C-épsilon/metabolismo , Sequência de Aminoácidos , Anáfase , Aurora Quinase B/química , Aurora Quinase B/genética , Pontos de Checagem do Ciclo Celular , Proteínas de Ciclo Celular/metabolismo , Linhagem Celular , Citocinese , Complexos Endossomais de Distribuição Requeridos para Transporte/metabolismo , Células HEK293 , Humanos , Modelos Biológicos , Mutação , Fosforilação , Proteína Quinase C-épsilon/antagonistas & inibidores , Proteína Quinase C-épsilon/genética , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Transdução de Sinais , Especificidade por Substrato
5.
Nat Commun ; 5: 5685, 2014 Dec 08.
Artigo em Inglês | MEDLINE | ID: mdl-25483024

RESUMO

Exit from mitosis is controlled by silencing of the spindle assembly checkpoint (SAC). It is important that preceding exit, all sister chromatid pairs are correctly bioriented, and that residual catenation is resolved, permitting complete sister chromatid separation in the ensuing anaphase. Here we determine that the metaphase response to catenation in mammalian cells operates through PKCε. The PKCε-controlled pathway regulates exit from the SAC only when mitotic cells are challenged by retained catenation and this delayed exit is characterized by BubR1-high and Mad2-low kinetochores. In addition, we show that this pathway is necessary to facilitate resolution of retained catenanes in mitosis. When delayed by catenation in mitosis, inhibition of PKCε results in premature entry into anaphase with PICH-positive strands and chromosome bridging. These findings demonstrate the importance of PKCε-mediated regulation in protection from loss of chromosome integrity in cells failing to resolve catenation in G2.


Assuntos
Mitose , Proteína Quinase C-épsilon/metabolismo , Fuso Acromático , Proteínas de Ciclo Celular/metabolismo , Separação Celular , Segregação de Cromossomos , Cromossomos/ultraestrutura , Dineínas/metabolismo , Citometria de Fluxo , Fase G2 , Inativação Gênica , Proteínas de Fluorescência Verde/metabolismo , Células HEK293 , Células HeLa , Humanos , Cinetocoros/metabolismo , Metáfase , Microscopia de Fluorescência , Neoplasias/metabolismo , RNA Interferente Pequeno/metabolismo , Troca de Cromátide Irmã
7.
ChemMedChem ; 5(1): 130-9, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19950162

RESUMO

Imatinib is a clinically important ATP analogue inhibitor that targets the tyrosine kinase domain of the intracellular Abl kinase and the PDGF receptor family. Imatinib has revolutionised the treatment of chronic myeloid leukaemia, which is caused by the oncogene Bcr-Abl and certain solid tumours that harbor oncogenic mutations of the PDGF receptor family. As a leading kinase inhibitor, imatinib also provides an excellent model system to investigate how changes in drug design impact biological activity, which is an important consideration for rational drug design. Herein we report a new series of imatinib derivatives that in general have greater activity against the family of PDGF receptors and poorer activity against Abl, as a result of modifications of the phenyl and N-methylpiperazine rings. These new compounds provide a platform for further drug development against the therapeutically important PDGF receptor family and they also provide insight into the engineering of drugs with altered biological activity.


Assuntos
Antineoplásicos/química , Proteínas de Fusão bcr-abl/metabolismo , Piperazinas/química , Inibidores de Proteínas Quinases/química , Proteínas Proto-Oncogênicas c-kit/metabolismo , Pirimidinas/química , Receptor de Fator Estimulador de Colônias de Macrófagos/metabolismo , Receptores do Fator de Crescimento Derivado de Plaquetas/metabolismo , Animais , Antineoplásicos/síntese química , Antineoplásicos/toxicidade , Benzamidas , Sítios de Ligação , Linhagem Celular Tumoral , Simulação por Computador , Desenho de Fármacos , Humanos , Mesilato de Imatinib , Células K562 , Camundongos , Fosforilação , Piperazinas/síntese química , Piperazinas/toxicidade , Inibidores de Proteínas Quinases/síntese química , Inibidores de Proteínas Quinases/toxicidade , Pirimidinas/síntese química , Pirimidinas/toxicidade , Especificidade por Substrato
8.
Cell Cycle ; 8(4): 549-55, 2009 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-19197162

RESUMO

Cell division requires the separation and partitioning of sister chromatids to opposite ends of the cell before an actomyosin ring contracts the membrane in between during cytokinesis. The final irreversible step occurs during abscission when the ring breaks down and the membrane is sealed in its place. The physical mechanics of contraction depend on RhoA, which is stimulated by a centralspindlin complex around the cell equator. However exactly how these events are reversed to allow actomyosin breakdown and abscission were not well understood. Here we will discuss new findings that implicate Protein Kinase C epsilon (PKCepsilon) as a regulator of RhoA signalling required for abscission.


Assuntos
Divisão Celular/fisiologia , Proteína Quinase C-épsilon/metabolismo , Proteína rhoA de Ligação ao GTP/metabolismo , Proteínas 14-3-3/metabolismo , Animais , Linhagem Celular , Humanos , Proteína Quinase C-épsilon/genética , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/metabolismo , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Fuso Acromático/metabolismo , Proteína rhoA de Ligação ao GTP/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA